122 related articles for article (PubMed ID: 565085)
1. Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs.
Gallimore MJ; Aasen AO; Lyngaas KH; Larsbraaten M; Amundsen E
Thromb Res; 1978 Feb; 12(2):307-18. PubMed ID: 565085
[No Abstract] [Full Text] [Related]
2. Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs.
Gallimore MJ; Aasen AO; Amundsen E
Haemostasis; 1978; 7(2-3):79-84. PubMed ID: 658781
[TBL] [Abstract][Full Text] [Related]
3. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta.
Hermann A; Buchinger P; Somlev B; Rehbock J
Placenta; 1996 May; 17(4):223-30. PubMed ID: 8761966
[TBL] [Abstract][Full Text] [Related]
4. Assay methods for prekallikrein and kininogens and their applications.
Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J
Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307
[TBL] [Abstract][Full Text] [Related]
5. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs.
Aasen AO; Frolich W; Saugstad OD; Amundsen E
Eur Surg Res; 1978; 10(1):50-62. PubMed ID: 344043
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
Yarovaya GA; Dotsenko VL; Orekhovich VN
Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
[TBL] [Abstract][Full Text] [Related]
7. Differences in prekallikrein and high molecular weight kininogen levels in two strains of Brown Norway rat (Kitasato strain and Katholiek strain).
Oh-ishi S; Satoh K; Hayashi I; Yamazaki K; Nakano T
Thromb Res; 1982 Oct; 28(1):143-7. PubMed ID: 6925403
[No Abstract] [Full Text] [Related]
8. Human plasma prekallikrein and high molecular weight kininogen decrease during parturition.
Alving BM; Niebyl JR; Proud D; Mason BL; Pisano JJ
Thromb Res; 1984 Jun; 34(6):473-7. PubMed ID: 6564799
[TBL] [Abstract][Full Text] [Related]
9. [Dynamics of components of the kallikrein-kinin system in the arterial and venous blood and cerebrospinal fluid of patients with severe cranio-cerebral injuries].
Valeev IK; Raĭzman SM; Tsibul'kin AP
Zh Vopr Neirokhir Im N N Burdenko; 1979; (1):27-30. PubMed ID: 425774
[TBL] [Abstract][Full Text] [Related]
10. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
[No Abstract] [Full Text] [Related]
11. Prekallikrein, HMW-kininogen and factor XII in various disease states.
Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein-kinin system in severe experimental hypertension.
Quadra JA; Bossolan D; Stella RC; Ribeiro AB; Kohlmann O; Ramos OL
Adv Exp Med Biol; 1986; 198 Pt B():313-9. PubMed ID: 3643729
[TBL] [Abstract][Full Text] [Related]
13. Changes in the kallikrein kinin system during acute pancreatitis in man.
Lasson A; Ohlsson K
Thromb Res; 1984 Jul; 35(1):27-41. PubMed ID: 6206588
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
[TBL] [Abstract][Full Text] [Related]
15. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
Donaldson VH; Kleniewski J; Saito H; Sayed JK
J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
[TBL] [Abstract][Full Text] [Related]
16. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
[TBL] [Abstract][Full Text] [Related]
17. The kinin-forming enzyme system in pregnancy and obstetrical DIC.
Maki M; Soga K; Gotoh K
Bibl Haematol; 1983; (49):239-46. PubMed ID: 6421272
[TBL] [Abstract][Full Text] [Related]
18. The effects of aprotinin on the phagocytic activity of the reticuloendothelial system and plasma prekallikrein levels during endotoxin shock.
Ogata H; Kim S; Fukazawa T; Midorikawa Y; Yamashiro C
Prog Clin Biol Res; 1983; 111():309-22. PubMed ID: 6191338
[No Abstract] [Full Text] [Related]
19. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
20. Kinin activation and protease inhibitors in acute pancreatitis in man.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
